Ralf Altenburger

Title: Ralf Altenburger: Innovator in Pharmaceutical Dosage Forms

Introduction

Ralf Altenburger is a notable inventor based in Eimeldingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the efficacy and efficiency of drug delivery systems.

Latest Patents

Ralf Altenburger holds a patent for a melt-processed imatinib dosage form. This invention provides a dosage form that includes a melt-processed mixture of a pharmaceutically effective amount of imatinib or a salt thereof, at least one polymeric binder, and at least one pharmaceutically acceptable non-ionic surfactant. The invention allows for high drug loading and can be prepared in a simple and efficient manner. It also ensures that the active principle is released in an essentially pH-independent fashion, along with offering extended release capabilities.

Career Highlights

Throughout his career, Ralf Altenburger has worked with prominent companies in the pharmaceutical industry. He has been associated with AbbVie Deutschland GmbH & Co. KG and Novartis AG, where he contributed to various innovative projects and advancements in drug formulation.

Collaborations

Ralf has collaborated with esteemed colleagues such as Jörg Breitenbach and Norbert Steiger. These partnerships have played a crucial role in the development of his patented technologies and have fostered a collaborative environment for innovation.

Conclusion

Ralf Altenburger's contributions to pharmaceutical dosage forms exemplify the importance of innovation in drug delivery systems. His work continues to influence the field and improve patient outcomes through advanced formulations.